<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" version="2.0">

<channel>
	<title>Meds Pages</title>
	
	<link>http://www.medspages.com</link>
	<description />
	<lastBuildDate>Mon, 06 Jun 2011 19:25:00 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/MedsPages" /><feedburner:info xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" uri="medspages" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">MedsPages</feedburner:emailServiceId><feedburner:feedburnerHostname xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">http://feedburner.google.com</feedburner:feedburnerHostname><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://add.my.yahoo.com/rss?url=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://us.i1.yimg.com/us.yimg.com/i/us/my/addtomyyahoo4.gif">Subscribe with My Yahoo!</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.newsgator.com/ngs/subscriber/subext.aspx?url=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://www.newsgator.com/images/ngsub1.gif">Subscribe with NewsGator</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://feeds.my.aol.com/add.jsp?url=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://o.aolcdn.com/favorites.my.aol.com/webmaster/ffclient/webroot/locale/en-US/images/myAOLButtonSmall.gif">Subscribe with My AOL</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.bloglines.com/sub/http://feeds.feedburner.com/MedsPages" src="http://www.bloglines.com/images/sub_modern11.gif">Subscribe with Bloglines</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.netvibes.com/subscribe.php?url=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://www.netvibes.com/img/add2netvibes.gif">Subscribe with Netvibes</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://fusion.google.com/add?feedurl=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://buttons.googlesyndication.com/fusion/add.gif">Subscribe with Google</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.pageflakes.com/subscribe.aspx?url=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://www.pageflakes.com/ImageFile.ashx?instanceId=Static_4&amp;fileName=ATP_blu_91x17.gif">Subscribe with Pageflakes</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.plusmo.com/add?url=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://plusmo.com/res/graphics/fbplusmo.gif">Subscribe with Plusmo</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.thefreedictionary.com/_/hp/AddRSS.aspx?http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://img.tfd.com/hp/addToTheFreeDictionary.gif">Subscribe with The Free Dictionary</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.bitty.com/manual/?contenttype=rssfeed&amp;contentvalue=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://www.bitty.com/img/bittychicklet_91x17.gif">Subscribe with Bitty Browser</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.newsalloy.com/?rss=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://www.newsalloy.com/subrss3.gif">Subscribe with NewsAlloy</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.live.com/?add=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://tkfiles.storage.msn.com/x1piYkpqHC_35nIp1gLE68-wvzLZO8iXl_JMledmJQXP-XTBOLfmQv4zhj4MhcWEJh_GtoBIiAl1Mjh-ndp9k47If7hTaFno0mxW9_i3p_5qQw">Subscribe with Live.com</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://mix.excite.eu/add?feedurl=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://image.excite.co.uk/mix/addtomix.gif">Subscribe with Excite MIX</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://download.attensa.com/app/get_attensa.html?feedurl=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://www.attensa.com/blogs/attensa/WindowsLiveWriter/BadgeredintoBadges_10C02/attensa_feed_button5.gif">Subscribe with Attensa for Outlook</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.webwag.com/wwgthis.php?url=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://www.webwag.com/images/wwgthis.gif">Subscribe with Webwag</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.podcastready.com/oneclick_bookmark.php?url=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://www.podcastready.com/images/podcastready_button.gif">Subscribe with Podcast Ready</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.flurry.com/pushRssFeed.do?r=fb&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://www.flurry.com/images/flurry_rss_logo2.gif">Subscribe with Flurry</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.wikio.com/subscribe?url=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://www.wikio.com/shared/img/add2wikio.gif">Subscribe with Wikio</feedburner:feedFlare><feedburner:feedFlare xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" href="http://www.dailyrotation.com/index.php?feed=http%3A%2F%2Ffeeds.feedburner.com%2FMedsPages" src="http://www.dailyrotation.com/rss-dr2.gif">Subscribe with Daily Rotation</feedburner:feedFlare><item>
		<title>General Practice Training – What Lies Ahead? Australia</title>
		<link>http://www.medspages.com/articles/general-practice-training-what-lies-ahead-australia/</link>
		<comments>http://www.medspages.com/articles/general-practice-training-what-lies-ahead-australia/#comments</comments>
		<pubDate>Mon, 06 Jun 2011 18:33:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Articles]]></category>

		<guid isPermaLink="false">http://www.medspages.com/articles/general-practice-training-what-lies-ahead-australia/</guid>
		<description><![CDATA[A supplement in the latest Medical Journal of Australia examines the past and the future for general practice training, including challenges in areas such as keeping training programs upto- date, Indigenous health, rural and remote health, aged care and military medicine. Professor Michael Kidd from Flinders University and co-editors of the supplement examine the past [...]]]></description>
			<content:encoded><![CDATA[<p>A supplement in the latest Medical Journal of Australia examines the past and the future for general practice training, including challenges in areas such as keeping training programs upto- date, Indigenous health, rural and remote health, aged care and military medicine. Professor Michael Kidd from Flinders University and co-editors of the supplement examine the past experiences, the contemporary issues and what lies ahead for general practice training. Prof Kidd said that there were many challenges for general practice in the years ahead&#8230; (Source: Health News from Medical News Today)</p>
<p>Further information:</p>
<p><a href="http://www.medworm.com/index.php?rid=4894171&#038;cid=u_0_26_f&#038;fid=23292&#038;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2F3Xjbx9jaWPM%2F227426.php" target="_blank">Article source</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.medspages.com/articles/general-practice-training-what-lies-ahead-australia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Landmark Breast Cancer Prevention Trial Finds Exemestane Significantly Reduces Risk Of Breast Cancer, Canada</title>
		<link>http://www.medspages.com/articles/landmark-breast-cancer-prevention-trial-finds-exemestane-significantly-reduces-risk-of-breast-cancer-canada/</link>
		<comments>http://www.medspages.com/articles/landmark-breast-cancer-prevention-trial-finds-exemestane-significantly-reduces-risk-of-breast-cancer-canada/#comments</comments>
		<pubDate>Mon, 06 Jun 2011 18:33:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Articles]]></category>

		<guid isPermaLink="false">http://www.medspages.com/articles/landmark-breast-cancer-prevention-trial-finds-exemestane-significantly-reduces-risk-of-breast-cancer-canada/</guid>
		<description><![CDATA[A large international Canadian-led clinical trial investigating a new way to prevent breast cancer in women at increased risk of developing the disease has found that the drug exemestane reduces this risk by 65 per cent compared with placebo. The results were presented today at the annual meeting of the American Society of Clinical Oncology [...]]]></description>
			<content:encoded><![CDATA[<p>A large international Canadian-led clinical trial investigating a new way to prevent breast cancer in women at increased risk of developing the disease has found that the drug exemestane reduces this risk by 65 per cent compared with placebo. The results were presented today at the annual meeting of the American Society of Clinical Oncology and published online by the New England Journal of Medicine. With funding from the Canadian Cancer Society, the NCIC Clinical Trials Group (CTG) led the trial which tested the drug exemestane, a member of a class of drugs called aromatase inhibitors&#8230; (Source: Health News from Medical News Today)</p>
<p>Further information:</p>
<p><a href="http://www.medworm.com/index.php?rid=4897798&#038;cid=u_0_26_f&#038;fid=23292&#038;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FJlsLlmZWVfM%2F227558.php" target="_blank">Article source</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.medspages.com/articles/landmark-breast-cancer-prevention-trial-finds-exemestane-significantly-reduces-risk-of-breast-cancer-canada/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NIH study models H1N1 flu spread</title>
		<link>http://www.medspages.com/press-releases/nih-study-models-h1n1-flu-spread/</link>
		<comments>http://www.medspages.com/press-releases/nih-study-models-h1n1-flu-spread/#comments</comments>
		<pubDate>Mon, 06 Jun 2011 18:33:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[New Press Releases]]></category>

		<guid isPermaLink="false">http://www.medspages.com/press-releases/nih-study-models-h1n1-flu-spread/</guid>
		<description><![CDATA[As the United States prepares for the upcoming flu season, a group of researchers supported by the National Institutes of Health continues to model how H1N1 may spread. Further information: Article source]]></description>
			<content:encoded><![CDATA[<p>As the United States prepares for the upcoming flu season, a group of researchers supported by the National Institutes of Health continues to model how H1N1 may spread.</p>
<p>Further information:</p>
<p><a href="http://www.nih.gov/news/health/sep2010/nigms-21.htm" target="_blank">Article source</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.medspages.com/press-releases/nih-study-models-h1n1-flu-spread/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Viewers look to TV characters to advise how to talk about sexual health</title>
		<link>http://www.medspages.com/press-releases/viewers-look-to-tv-characters-to-advise-how-to-talk-about-sexual-health/</link>
		<comments>http://www.medspages.com/press-releases/viewers-look-to-tv-characters-to-advise-how-to-talk-about-sexual-health/#comments</comments>
		<pubDate>Mon, 06 Jun 2011 18:33:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[New Press Releases]]></category>

		<guid isPermaLink="false">http://www.medspages.com/press-releases/viewers-look-to-tv-characters-to-advise-how-to-talk-about-sexual-health/</guid>
		<description><![CDATA[(Ohio State University) &#8220;What would Samantha and Miranda do?&#8221; That&#8217;s what viewers of the past HBO series &#8220;Sex and the City&#8221; may ask themselves when faced with the prospect of uncomfortable discussions about sexual health with partners, friends and doctors. Researchers found that college students were more than twice as likely to talk about sexual [...]]]></description>
			<content:encoded><![CDATA[<p>(<i>Ohio State University</i>) &#8220;What would Samantha and Miranda do?&#8221;  That&#8217;s what viewers of the past HBO series &#8220;Sex and the City&#8221; may ask themselves when faced with the prospect of uncomfortable discussions about sexual health with partners, friends and doctors.  Researchers found that college students were more than twice as likely to talk about sexual health issues with their partners after watching a &#8220;Sex and the City&#8221; episode.</p>
<p>Further information:</p>
<p><a href="http://www.eurekalert.org/pub_releases/2011-06/osu-vlt060111.php" target="_blank">Article source</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.medspages.com/press-releases/viewers-look-to-tv-characters-to-advise-how-to-talk-about-sexual-health/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medicourse.com Now Fully Live After 3 Months Beta Testing</title>
		<link>http://www.medspages.com/press-releases/medicourse-com-now-fully-live-after-3-months-beta-testing/</link>
		<comments>http://www.medspages.com/press-releases/medicourse-com-now-fully-live-after-3-months-beta-testing/#comments</comments>
		<pubDate>Mon, 06 Jun 2011 18:33:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[New Press Releases]]></category>

		<guid isPermaLink="false">http://www.medspages.com/press-releases/medicourse-com-now-fully-live-after-3-months-beta-testing/</guid>
		<description><![CDATA[NewswireToday (newswire) &#8211; 06/02/2011 Bolton, Lancashire United Kingdom &#8211; This unique and innovative medical and healthcare search engine is the first component of an interactive and searchable global directory system for the marketing of all medical and healthcare events, training courses and medical CPD Further information: Article source]]></description>
			<content:encoded><![CDATA[<p>NewswireToday (newswire) &#8211; 06/02/2011 Bolton, Lancashire United Kingdom &#8211; This unique and innovative medical and healthcare search engine is the first component of an interactive and searchable global directory system for the marketing of all medical and healthcare events, training courses and medical CPD</p>
<p>Further information:</p>
<p><a href="http://www.newswiretoday.com/news/91654/" target="_blank">Article source</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.medspages.com/press-releases/medicourse-com-now-fully-live-after-3-months-beta-testing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CWRU researcher studies ways to help teens overcome fears and stigmas of mental illness</title>
		<link>http://www.medspages.com/press-releases/cwru-researcher-studies-ways-to-help-teens-overcome-fears-and-stigmas-of-mental-illness/</link>
		<comments>http://www.medspages.com/press-releases/cwru-researcher-studies-ways-to-help-teens-overcome-fears-and-stigmas-of-mental-illness/#comments</comments>
		<pubDate>Mon, 06 Jun 2011 18:33:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[New Press Releases]]></category>

		<guid isPermaLink="false">http://www.medspages.com/press-releases/cwru-researcher-studies-ways-to-help-teens-overcome-fears-and-stigmas-of-mental-illness/</guid>
		<description><![CDATA[(Case Western Reserve University) Case Western Reserve University KL2 Clinical Research Scholar and Instructor Melissa Pinto-Foltz from the Frances Payne Bolton School of Nursing wants to find the magical elixir that helps teens speak up, seek help and then stick with treatments that get them feeling better. Further information: Article source]]></description>
			<content:encoded><![CDATA[<p>(<i>Case Western Reserve University</i>) Case Western Reserve University KL2 Clinical Research Scholar and Instructor Melissa Pinto-Foltz from the Frances Payne Bolton School of Nursing wants to find the magical elixir that helps teens speak up, seek help and then stick with treatments that get them feeling better.   </p>
<p>Further information:</p>
<p><a href="http://www.eurekalert.org/pub_releases/2011-06/cwru-crs060611.php" target="_blank">Article source</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.medspages.com/press-releases/cwru-researcher-studies-ways-to-help-teens-overcome-fears-and-stigmas-of-mental-illness/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>7 Dirt-Cheap Takeover Targets in Biotech</title>
		<link>http://www.medspages.com/articles/7-dirt-cheap-takeover-targets-in-biotech/</link>
		<comments>http://www.medspages.com/articles/7-dirt-cheap-takeover-targets-in-biotech/#comments</comments>
		<pubDate>Mon, 06 Jun 2011 18:33:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Articles]]></category>

		<guid isPermaLink="false">http://www.medspages.com/articles/7-dirt-cheap-takeover-targets-in-biotech/</guid>
		<description><![CDATA[Rougemont submits: Biotechs and healthcare stocks have been outperfoming the market. These dirt-cheap biotech companies all have interesting products in the pipeline that could become major catalysts in the future. The lower-priced stocks tend to have more risk, but far more potential reward. The stocks below are trading at valuations that appear to be a [...]]]></description>
			<content:encoded><![CDATA[<p>        <strong><a href='http://seekingalpha.com/author/rougemont'>Rougemont</a> submits: </strong>
<div>Biotechs and healthcare stocks have been outperfoming the market.  These dirt-cheap biotech companies all have interesting products in the pipeline that could become major catalysts in the future.  The lower-priced stocks tend to have more risk, but far more potential reward.  The stocks below are trading at valuations that appear to be a buying opportunity that could provide for very substantial gains.  Many of these stocks fell from their long term highs, on analyst downgrades and other issues.  Others have been seemingly ignored by the stock market and do not appear to be fully valued.  There is nothing better than buying a stock at a very low price and watching it become worth several times your initial investment.  Some of these stocks have spiked up lately &#8212; names like Inhibitex (<a href='http://seekingalpha.com/symbol/inhx' title='Inhibitex, Inc.'>INHX</a>), Acorda (<a href='http://seekingalpha.com/symbol/acor' title='Acorda Therapeutics, Inc.'>ACOR</a>), and Biosante (<a href='http://seekingalpha.com/symbol/bpax' title='Biosante Pharmaceuticals, Inc.'>BPAX</a>) &#8212; so I would wait for pullbacks.  However, others like Catalyst Pharmaceutical Partners (<a href='http://seekingalpha.com/symbol/cprx' title='Catalyst Pharmaceutical Partners, Inc.'>CPRX</a>)</div>
<p><br/><a href='http://seekingalpha.com/article/273181-7-dirt-cheap-takeover-targets-in-biotech?source=feed'>Complete Story &raquo;</a></p>
<p>Further information:</p>
<p><a href="http://seekingalpha.com/article/273181-7-dirt-cheap-takeover-targets-in-biotech?source=feed" target="_blank">Article source</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.medspages.com/articles/7-dirt-cheap-takeover-targets-in-biotech/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stand Up for your Patent Rights! At last, Intellectual Property Insurance that allows SMEs to fight for their patents in court.</title>
		<link>http://www.medspages.com/press-releases/stand-up-for-your-patent-rights-at-last-intellectual-property-insurance-that-allows-smes-to-fight-for-their-patents-in-court/</link>
		<comments>http://www.medspages.com/press-releases/stand-up-for-your-patent-rights-at-last-intellectual-property-insurance-that-allows-smes-to-fight-for-their-patents-in-court/#comments</comments>
		<pubDate>Mon, 06 Jun 2011 18:33:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[New Press Releases]]></category>

		<guid isPermaLink="false">http://www.medspages.com/press-releases/stand-up-for-your-patent-rights-at-last-intellectual-property-insurance-that-allows-smes-to-fight-for-their-patents-in-court/</guid>
		<description><![CDATA[Patenting your ideas is important – but it’s crucial to protect them with proper insurance too. La Playa’s Matthew Clark celebrates the arrival of a new insurance product that’s made for SMEs. Intellectual Property is arguably your most important asset – but could you actually afford to defend a patent? An average patent law suit [...]]]></description>
			<content:encoded><![CDATA[<p>Patenting your ideas is important – but it’s crucial to protect them with proper insurance too.  La Playa’s Matthew Clark celebrates the arrival of a new insurance product that’s made for SMEs.</p>
<p>Intellectual Property is arguably your most important asset – but could you actually afford to defend a patent?  An average patent law suit in the United Kingdom can easily exceed £250,000 (per side).</p>
<p>Much has been written about the importance of patents to support the growth of the knowledge economy.  Yet patent owners receive no government or patent office help when faced with having to enforce their patent rights if they are infringed or if their validity or ownership is challenged. Who would you turn to for help in defending your rights?  This is particularly an issue for SMEs, many of whom would be forced to “roll over” rather than pay the legal costs to defend their intellectual property.</p>
<p>You wouldn&#8217;t hesitate to insure office contents and other assets &#8211; so why leave your patents unprotected?  Without insurance, the financial burden of a patent infringement case can be tremendous -crippling for start-ups and smaller businesses.  But with the right insurance policy in place, you have the financial muscle to defend yourself – and merely having the insurance is itself a powerful deterrent to any potential infringer.</p>
<p>Intellectual Property insurance has long been available to large companies – but at a price; smaller firms have struggled to find affordable cover.  Cambridge and London based insurance specialist La Playa has teamed up with leading global IP insurer SAMIAN Underwriting Agency, to provide <a href='http://www.laplaya.co.uk/intellectual-property.htm' target='_blank'>PatentEnforcerTM</a> &#8211; a cost effective insurance solution to protect the fruits of your invention with the financial means to enforce your patent rights.  PatentEnforcerTM is specifically designed for the SME market, with sensible levels of protection at reasonable prices, and the cover allows you to pursue infringers of your intellectual property.  </p>
<p>More information and online quotations for <a href='http://www.laplaya.co.uk/intellectual-property.htm' target='_blank'>Intellectual Property Insurance</a> are available online.</p>
<p>Press information and photographs: Arianne Rosmolen, Marketing &#038; Administration Assistant  <br />
Tel: (01223) 200668 email: <a title=Sends&nbsp;email&nbsp;to:&nbsp;arianne.rosmolen href="mailto:arianne.rosmolen@laplayainsurance.com">arianne.rosmolen@laplayainsurance.com</a><br />
ENDS/</p>
<p>Notes for editors:</p>
<p>Contact details:<br />
Matthew Clark, Director: Science &#038; Technology T: 01223 200667 E: <a title=Sends&nbsp;email&nbsp;to:&nbsp;matthew.clark href="mailto:matthew.clark@laplayainsurance.com">matthew.clark@laplayainsurance.com</a><br />
Arianne Rosmolen, Marketing &#038; Admin Asst T: (01223) 200668 E: <a title=Sends&nbsp;email&nbsp;to:&nbsp;arianne.rosmolen href="mailto:arianne.rosmolen@laplayainsurance.com">arianne.rosmolen@laplayainsurance.com</a></p>
<p>Website: <a title='Goes&nbsp;to&nbsp;website&nbsp;of:&nbsp;www.laplayainsurance.com' href='http://www.laplayainsurance.com' target='_blank'>www.laplayainsurance.com</a></p>
<p>Established in 1999, La Playa is an award-winning independent broker supporting science and technology companies with practical, jargon-free insurance advice.</p>
<p>SPECIALIST INSURANCE &#038; RISK MANAGEMENT ADVICE<br />
● Exceptional personal service <br />
● Tailor-made insurance &#038; risk control programmes<br />
● Valuable due diligence services for entrepreneurs &#038; investors<br />
● Your advocate during claims<br />
● Simple set-up with electronic administration<br />
<img src="http://feeds.feedburner.com/~r/ReleaseWireMedicalAndPharmaceutical/~4/B8iySZnZW2g" height="1" width="1"/></p>
<p>Further information:</p>
<p><a href="http://feedproxy.google.com/~r/ReleaseWireMedicalAndPharmaceutical/~3/B8iySZnZW2g/rel_display.php" target="_blank">Article source</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.medspages.com/press-releases/stand-up-for-your-patent-rights-at-last-intellectual-property-insurance-that-allows-smes-to-fight-for-their-patents-in-court/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Estimates of Outcomes Up to Ten Years after Stroke: Analysis from the Prospective South London Stroke Register</title>
		<link>http://www.medspages.com/articles/estimates-of-outcomes-up-to-ten-years-after-stroke-analysis-from-the-prospective-south-london-stroke-register/</link>
		<comments>http://www.medspages.com/articles/estimates-of-outcomes-up-to-ten-years-after-stroke-analysis-from-the-prospective-south-london-stroke-register/#comments</comments>
		<pubDate>Mon, 06 Jun 2011 18:33:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Articles]]></category>

		<guid isPermaLink="false">http://www.medspages.com/articles/estimates-of-outcomes-up-to-ten-years-after-stroke-analysis-from-the-prospective-south-london-stroke-register/</guid>
		<description><![CDATA[by Charles D. A. Wolfe, Siobhan L. Crichton, Peter U. Heuschmann, Christopher J. McKevitt, André M. Toschke, Andy P. Grieve, Anthony G. Rudd Background Although stroke is acknowledged as a long-term condition, population estimates of outcomes longer term are lacking. Such estimates would be useful for planning health services and developing research that might ultimately [...]]]></description>
			<content:encoded><![CDATA[<p>by Charles D. A. Wolfe, Siobhan L. Crichton, Peter U. Heuschmann, Christopher J. McKevitt, André M. Toschke, Andy P. Grieve, Anthony G. Rudd</p>
<p>Background
<p>Although stroke is acknowledged as a long-term condition, population<br />
                        estimates of outcomes longer term are lacking. Such estimates would be<br />
                        useful for planning health services and developing research that might<br />
                        ultimately improve outcomes. This burden of disease study provides<br />
                        population-based estimates of outcomes with a focus on disability,<br />
                        cognition, and psychological outcomes up to 10 y after initial stroke event<br />
                        in a multi-ethnic European population.</p>
<p> Methods and Findings
<p>Data were collected from the population-based South London Stroke Register, a<br />
                        prospective population-based register documenting all first in a lifetime<br />
                        strokes since 1 January 1995 in a multi-ethnic inner city population. The<br />
                        outcomes assessed are reported as estimates of need and included disability<br />
                        (Barthel Index <15), inactivity (Frenchay Activities Index <15),<br />
                        cognitive impairment (Abbreviated Mental Test < 8 or Mini-Mental State<br />
                        Exam <24), anxiety and depression (Hospital Anxiety and Depression Scale<br />
                        >10), and mental and physical domain scores of the Medical Outcomes Study<br />
                        12-item short form (SF-12) health survey. Estimates were stratified by age,<br />
                        gender, and ethnicity, and age-adjusted using the standard European<br />
                        population. Plots of outcome estimates over time were constructed to examine<br />
                        temporal trends and sociodemographic differences. Between 1995 and 2006,<br />
                        3,373 first-ever strokes were registered: 20%–30% of<br />
                        survivors had a poor outcome over 10 y of follow-up. The highest rate of<br />
                        disability was observed 7 d after stroke and remained at around 110 per<br />
                        1,000 stroke survivors from 3 mo to 10 y. Rates of inactivity and cognitive<br />
                        impairment both declined up to 1 y (280/1,000 and 180/1,000 survivors,<br />
                        respectively); thereafter rates of inactivity remained stable till year<br />
                        eight, then increased, whereas rates of cognitive impairment fluctuated till<br />
                        year eight, then increased. Anxiety and depression showed some fluctuation<br />
                        over time, with a rate of 350 and 310 per 1,000 stroke survivors,<br />
                        respectively. SF-12 scores showed little variation from 3 mo to 10 y after<br />
                        stroke. Inactivity was higher in males at all time points, and in white<br />
                        compared to black stroke survivors, although black survivors reported better<br />
                        outcomes in the SF-12 physical domain. No other major differences were<br />
                        observed by gender or ethnicity. Increased age was associated with higher<br />
                        rates of disability, inactivity, and cognitive impairment.</p>
<p> Conclusions
<p>Between 20% and 30% of stroke survivors have a poor range of<br />
                        outcomes up to 10 y after stroke. Such epidemiological data demonstrate the<br />
                        sociodemographic groups that are most affected longer term and should be<br />
                        used to develop longer term management strategies that reduce the<br />
                        significant poor outcomes of this group, for whom effective interventions<br />
                        are currently elusive.</p>
<p>
            <i>Please see later in the article for the Editors&#8217; Summary</i>
          </p>
<p><img src="http://feeds.feedburner.com/~r/plosmedicine/NewArticles/~4/qjoqzIozbog" height="1" width="1"/></p>
<p>Further information:</p>
<p><a href="http://feeds.plos.org/~r/plosmedicine/NewArticles/~3/qjoqzIozbog/info%3Adoi%2F10.1371%2Fjournal.pmed.1001033" target="_blank">Article source</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.medspages.com/articles/estimates-of-outcomes-up-to-ten-years-after-stroke-analysis-from-the-prospective-south-london-stroke-register/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Strain of MRSA Found in Milk</title>
		<link>http://www.medspages.com/articles/new-strain-of-mrsa-found-in-milk/</link>
		<comments>http://www.medspages.com/articles/new-strain-of-mrsa-found-in-milk/#comments</comments>
		<pubDate>Mon, 06 Jun 2011 18:33:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Articles]]></category>

		<guid isPermaLink="false">http://www.medspages.com/articles/new-strain-of-mrsa-found-in-milk/</guid>
		<description><![CDATA[Title: New Strain of MRSA Found in MilkCategory: Health NewsCreated: 6/3/2011 11:00:00 AMLast Editorial Review: 6/3/2011 Further information: Article source]]></description>
			<content:encoded><![CDATA[<p>Title: New Strain of MRSA Found in Milk<br />Category: Health News<br />Created: 6/3/2011 11:00:00 AM<br />Last Editorial Review: 6/3/2011</p>
<p>Further information:</p>
<p><a href="http://www.medicinenet.com/guide.asp?s=rss&#038;k=DailyHealth&#038;a=145133" target="_blank">Article source</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.medspages.com/articles/new-strain-of-mrsa-found-in-milk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

